Moreover, patients with S100A6 serum levels of less than 2234 ng/ml displayed a trend towards a better survival in Kaplan–Meier curve analysis, highlighting that S100A6 serum levels might reflect prognosis-relevant processes in patients with CCA. The gene discussed is S100A6; the disease is cholangiocarcinoma.